Nutritional impact of inflammatory bowel diseases on children and adolescents^☆

Abstracts

OBJECTIVE:

To perform a sistematiy review of the literature about the nutritional impact of inflammatory bowel diseases in children and adolescents.

DATA SOURCES:

A systematic review was performed using PubMed/MEDLINE, LILACS and SciELO databases, with inclusion of articles in Portuguese and in English with original data, that analyzed nutritional aspects of inflammatory bowel diseases in children and adolescents. The initial search used the terms "inflammatory bowel diseases" and "children" or "adolescents" and "nutritional evaluation" or "nutrition deficiency". The selection of studies was initially performed by reading the titles and abstracts. Review studies and those withouth data for pediatric patients were excluded. Subsequently, the full reading of the articles considered relevant was performed.

RESULTS:

237 studies were identified, and 12 of them were selected according to the inclusion criteria. None of them was performed in South America. During the analysis of the studies, it was observed that nutritional characteristics of patients with inflammatory bowel disease may be altered; the main reports were related to malnutrition, growth stunting, delayed puberty and vitamin D deficiency.

CONCLUSION:

There are nutritional consequences of inflammatory bowel diseases in children and adolescents, mainly growth stunting, slower pubertal development, underweight and vitamin deficiencies. Nutritional impairments were more significant in patients with Crohn's disease; overweight and obesity were more common in patients with ulcerative rectocolitis. A detailed nutritional assessment should be performed periodically in children and adolescents with inflammatory bowel disease.

Nutritional assessment; Nutritional status; Inflammatory bowel diseases; Child; Adolescent

OBJETIVO:

Realizar revisão sistemática de literatura sobre repercussões nutricionais em crianças e adolescentes na presença de doenças inflamatórias intestinais.

FONTES DE DADOS:

Realizada revisão sistemática utilizando as bases de dados PubMed/MEDLINE, LILACS e SciELO, com inclusão de artigos em língua portuguesa e inglesa com dados originais que analisaram aspectos nutricionais de crianças ou adolescentes com doenças inflamatórias intestinais. Na busca inicial, utilizaram-se os termos "inflammatory bowel diseases" and "children" or "adolescents" and "nutritional evaluation" or "nutrition deficiency". A seleção de estudos foi feita, inicialmente, por meio da leitura dos títulos e resumos. Foram excluídos estudos de revisão e sem resultados para faixa pediátrica. Em um segundo momento, foi realizada leitura completa dos artigos considerados relevantes.

SÍNTESE DE DADOS:

Foram identificados 237 estudos - desses, 12 foram selecionados de acordo com os critérios de inclusão, não havendo nenhum na América do Sul. Na análise dos artigos, foi observado que características nutricionais em pacientes com doenças inflamatórias intestinais podem estar alteradas, sendo relatados principalmente desnutrição, retardo de crescimento e puberdade e deficiência de vitamina D.

CONCLUSÃO:

Há alterações nutricionais nas doenças inflamatórias intestinais em pediatria, ressaltando-se parada no crescimento e desenvolvimento puberal, baixo peso e deficiências vitamínicas. Os comprometimentos nutricionais relatados são mais expressivos nos pacientes portadores de Doença de Crohn, e sobrepeso e obesidade mais frequentes na Retocolite Ulcerativa. A avaliação nutricional detalhada deve ser realizada periodicamente em todas crianças e adolescentes portadores de doenças inflamatórias intestinais.

Avaliação nutricional; Estado nutricional; Doenças inflamatórias intestinais; Criança; Adolescente

Introduction

Inflammatory bowel diseases (IBDs) are represented by ulcerative rectocolitis (URC), Crohn's disease (CD) and indeterminate colitis,¹ which affect the gastrointestinal tract in different ways, mainly the ileum and other segments of the jejunum, very often the colon in CD and only the colon and/or rectum in URC. These diseases have overlapping clinical and pathological characteristics; however, some have distinct features.^{2 , 3}

There are several predisposing factors for their onset, such as genetic, environmental, and immunological factors, and an important role is played by the intestinal microbiota imbalance, as well as by changes in mucosal permeability and immune response. The risk factor to be emphasized is the reporting of similar cases in the family, especially in first-degree relatives.^{4 , 5} IBDs have a worldwide distribution, with increasing incidence in recent decades in all geographic areas, with two peaks of incidence, one in adolescence and another in adulthood. Children are also affected, and the incidence in this age range is also increasing.⁶

In CD there is transmural inflammation affecting any segment of the gastrointestinal tract, from mouth to anus, especially distal small intestine and colon, while URC is restricted to the mucosa and submucosa and can involve the colon and rectum. Both can have extraintestinal manifestations and variable severity. When clinical, radiological, endoscopic and histopathological criteria are not completely consistent, the disease is classified as indeterminate colitis.^{7 , 8}

Nutrition is an extremely important aspect for patients with chronic diseases, especially in the pediatric age range. Nutritional problems are common in patients with IBDs, accompanied by clinical exacerbation of disease activity and remission, depending on the activity, the location, extension, severity and presence of complications. Nutritional changes can be identified in 20-85% of patients, especially in patients with CD.^{9 , 10}

There may be growth delay, malnutrition, specific micronutrient deficiencies, or eventually even overweight and obesity. The determinants of nutritional changes are: reduction of food intake, intestinal malabsorption, gastrointestinal losses due to inflammation, increased nutritional needs due to disease activity, concomitant infections, reduced food intake due to decreased appetite or due to fear of worsening symptoms, immunosuppressive treatment, side effects of medications and even surgical resections, and other systemic complications and involvement of other organs, which may cause weight loss, anemia, anorexia, hypoalbuminemia, negative nitrogen balance and nutrient and vitamin deficiencies.^{11 - 13}

IBDs can cause manifestations of the digestive tract as well as extradigestive ones. These conditions also determine several psychosocial and economic problems, missed days at work and school, depression, change in body image and low self-esteem, sexuality and socialization difficulties, feeding difficulties, fear to leave the house and not finding a public restroom available, among others, which limit the quality of life. Patients also report feeding problems, a fact that contributes to the worsening of the nutritional impairment, to the development of anemia, stunted growth and systemic complications.¹⁴

Nutritional alterations represent public health problems, which affect all strata of society. IBDs can aggravate nutritional deficiencies, causing malnutrition, but in some cases they may be associated with overweight as a result of drugs and aspects of binge eating. Inadequate nutritional status is a poor prognosis and may influence treatment response, as well as morbidity and mortality.^{15 , 16}

Nutritional assessment is of great importance for all pediatric patients, especially those with IBDs, allowing early identification of nutritional alterations, and it can be performed with anthropometric data, biochemical indices, sophisticated tests, and even through nutritional survey.^{18 , 19} One of the most used methods is the assessment of Body Mass Index (BMI), calculated by dividing the patient's weight by the squared height. Based on the BMI vs. age charts and the z score, one can classify the nutritional status of children.^{20 , 21} Adequate nutritional status, growth and development are key aspects in pediatric patients from the neonatal period to adolescence, particularly in patients with chronic diseases.

There is a scarcity of studies on nutritional assessment in pediatric patients with IBDs,³ and there have been no reports in children and adolescents in Brazil. This study aimed to perform a systematic review on the nutritional implications of the presence of IBDs in children and adolescents.

Method

To develop this study, a systematic review was performed in PubMed/ MEDLINE, SciELO and LILACS databases to identify the literature published from January 2006 to January 2013, using the following terms: (Nutritional assessment OR nutritional disorders OR body compositions) AND (Inflammatory bowel diseases OR Crohn disease OR ulcerative disease) AND (Children OR pediatrics OR adolescents). Only studies published in Portuguese and English, with original data that analyzed dietary habits of children and adolescents with IBDs were included. Review studies and those with no results for pediatric patients were excluded.

Study selection was initially performed by reading the titles and abstracts of articles. In the second phase, the reading of the methods section was performed, and in the third phase, the reading of the full texts was carried out. The non-relevant articles were discarded (Fig. 1). After analyzing and interpreting the articles, the information was organized in thematic groups. As this is a systematic review, it was not necessary to submit the study to the ethics committee for approval.

Figure 1
Flowchart of the systematic review of inflammatory bowel diseases in the pediatric age range and nutritional aspects

Results

After the search for published articles on the topic, the review identified 237 studies published during the defined period on the nutritional aspects of children and adolescents with IBDs. A total of 223 articles were found in PubMed, 10 in LILACS and 4 in SciELO. After exclusions, 12 articles were selected for final assessment, and they comprised this systematic review (Fig. 1). The selected studies were carried out in four countries: United States, United Kingdom, Australia and Pakistan, with nine of them having been carried out in the United States. There were no studies carried out in Brazil. The list is shown in Table 1.

Table 1
Characteristics and description of studies on nutritional aspects in children and adolescents with inflammatory bowel diseases included in the systematic review.

Author/Year /local	Objective	Sample/ controls/Age	Main Results	CD X URC	Conclusion
Pappa et al[30] 2006 USA	Report the prevalence of vitamin D deficiency in IBD	n. 130/ c. 0/ 8 months-2 years	The prevalence of vitamin D deficiency was 34.6 %.	Mean serum [25 OHD] was similar in patients with CD and URC	Vitamin D deficiency is highly prevalent among pediatric patients with IBD.
Kugathasan et al[25] 2007 USA	Compare the BMI of all children with a recent diagnosis of IBD in two independent groups	n. 783/ c. 2,748/ <16 years	Most children with IBD had normal BMI (5% 84%).	BMI <5% was observed in 24% of children with CD and 9% in URC. 10% of the children with CD and 30% of those with URC had BMI consistent with overweight or risk of overweight.	Children with IBD are affected by current population trends in relation to overweight. A subgroup of children with newly diagnosed IBD has a BMI classified as overweight or at risk of overweight.
Thayu et al[28] 2007 USA	To evaluate lean mass and fat mass in children and adolescents with CD at diagnosis.	n. 78/c. 669/ 5-21 years	CD was associated with height, BMI, lean and fat mass that was low for age.		CD was associated with deficits in lean mass and fat mass.
Sylvester et al[33] 2009 USA	Observe the effects of CD on body composition in a cohort of children over a period of two years	n. 42/ c. 81/ 6-17 years	BMI z was reduced at diagnosis in children with CD compared with controls. During the study period of 2 years, BMI z scores will normalize in patients with CD.		The correction of BMI is associated with clinical improvement in children with CD two years after diagnosis
Heyman et al[32] 2009 USA	Compare folate concentrations between children with newly diagnosed IBD and healthy controls	n. 37/ c. 41/ 5 to 17 years	Serum folate concentrations were 11.1% lower in controls than in patients with IBD (p=0.031).		Higher folate concentrations were observed in children with newly diagnosed untreated IBD than in the controls.
Lee et al[26] 2010 USA	Compare final adult height of patients and the target height based on the heights of parents.	n. 295/c. 569/ 1-18 years	22% had impaired growth (zH /A<-1.64, equivalent to percentile <5). Only 11.3% with impaired growth up to adulthood.	Most patients with growth problems had CD (88% CD vs. 12% URC)	Most patients with IBD do not persist with impaired growth in adulthood.
Long et al[24]2011 USA	Determine the prevalence of obesity in a multicentric cohort of children with IBD	n. 1,598/ c. 0/ 2-18 years	The prevalence of overweight and obesity in children and adolescents with IBD was 23.6%.	Higher rates of overweight and obesity were found in URC than in CD (30.1% and 20.0%, respectively)	Approximately 1/5 of children with CD and 1/3 with URC are overweight or obese. Obesity rate in URC is comparable to that of the general population.
Pappa et al[29] 2011 USA	To evaluate the prevalence of hypovitaminosis D in children and adolescents with IBD.	n. 448/ c. /8-22 years	Serum [25-OHD] ≤20ng/mL (insufficiency) identified in 14.3% of patients and serum [25-OHD] ≤15ng/mL (deficiency) in 5.8%.	Both patients with URC and CD are at risk of hypovitaminosis D.	Hypovitaminosis D is prevalent among children and young individuals, including patients with IBD.
Levin et al[31] 2011 Australia	Document the 25-OHD status in a population of Australian children with IBD.	n. 78/ c. 0/ mean age of 12.6 (±3.5) years	19% of the children had vitamin D deficiency and 38% had vitamin D insufficiency.		A high proportion of Australian children with IBD were vitamin-D deficient.
Wiskin et al[23] 2011 UK	Describe the height, weight and body composition in a cohort of children with IBD.	n. 55/ c. 0/ 6.5-17.7 years	Malnutrition rate, according to the WHO criteria, was 2.2%. Growth deficit of 18.2% among the studied children.	Nutritional deficits were more common in Crohn's disease	Most children showed satisfactory height and weight, although some children were underweight for height and others were overweight.
Aurangzeb et al[22] 2011 Pakistan	Define the nutritional status of children with newly diagnosed IBD	n. 28 c. 56 6 months to 16 years	Children with IBD have BMI z score and weight percentile for age lower than controls (p=0.05 and p=0.01, respectively)		Detailed nutritional assessment should be an integral part of the conduct for all children with IBD.
Hood et al[27] 2011 USA	Compare heights at expected age of cessation of growth (16 for girls and 18 for boys) with those obtained after two years.	n. 475/ c. 0/ 16-20 years	Compared to the general population (163.8 cm at age 16 in girls and 176.8 cm at age 18 in boys), girls and boys with IBD were 2.7 cm and 2.6 cm shorter, respectively.		Most patients with IBD reach adult height within normal values for the population.

• IBD, Inflammatory bowel diseases; CD, Crohn's disease; URC, Ulcerative Rectocolitis; 25 OHD, 25-hydroxyvitamin D; BMI, body mass index.

Nutritional Characteristics in IBDs

The analyzed studies showed that pediatric IBD patients, especially those with CD, have alterations in nutritional status, and malnutrition is frequently reported. Aurangzeb et al ²² studied 28 children with IBD and compared them with healthy children. The first showed lower BMI z score and lower weight for age (p=0.05 and p=0.01, respectively), and lower levels of leptin, suggesting malnutrition. Almost half of these children were diagnosed in the age group of 9-12 years (prepubertal or pubertal), with the presence of nutritional impairment in an important phase of growth and development. Wiskin et al ²³ assessed 55 children with IBD and found a malnutrition rate of 2.2%, according to the WHO criteria.

There is a tendency for underweight in patients with IBDs, but studies have shown some changes in that profile, such as an increase in the number of overweight or obese individuals in recent years, especially in those with URC. Long et al ²⁴ assessed the prevalence and epidemiology of obesity in 1,598 children and adolescents aged 2-18 years with IBD and found that 23.6% were obese or overweight. The study suggests that, with the advent of treatments for IBDs, malnutrition and underweight may cease to be a marker of IBD severity, with children showing high rates of overweight and obesity, as well as the general population. Kugathasan et al ²⁵ assessed 783 patients with IBD and showed that the majority (68%) was within the normal weight range, and that of the newly diagnosed patients with IBDs, 9-34%, depending on the type, were overweight - at a lower rate (7-24%), they had underweight or underweight risk.

Growth delay is common in patients with a diagnosis of IBD in childhood and this may be the only symptom. Wiskin et al, ²³ in 2011, observed growth delay in 18.2% of the children studied. Lee et al,²⁶ also in 2011, assessed 295 patients with IBD diagnosed between the ages of 1-18 years in a prospective cohort study and found that 22% had growth problems, according to the z score of height for age. The same authors observed a growth curve with a slight shift to the left in patients with IBD, while 11.3% of these patients had impaired final adult height. The same authors also found that patients with growth problems achieve lower mean final target height than healthy individuals.

Hood et al,²⁷ in 2011, assessed 475 men and women with IBD aged 16, 18 and 20 years to evaluate the final adult height and found no significant differences between the height of patients with IBD and that of healthy individuals, despite the identified growth problems. These authors emphasize the importance of identifying patients with early growth retardation. Aurangzeb et al ²² and Hood et al ²⁷ reported that those diagnosed in the prepubertal or pubertal stages are more vulnerable to pubertal and growth delay, and consequently, to a compromised final height, especially if the diagnosis occurs before Tanner stages 1 and 2. Thayu et al ²⁸ analyzed 78 patients with CD and 669 controls aged 5 to 21 years and found older age for the same Tanner stage in CD patients, demonstrating that, in association with growth retardation, children and adolescents with IBDs often have pubertal delay.

Nutrient and vitamin deficiencies are reported, mainly vitamin D deficiency. Pappa et al,²⁹ in 2011, assessed 448 patients with IBD and showed that hypovitaminosis D is prevalent in children and adolescents. At least one measurement of serum 25-hydroxyvitamin D (25-OHD) was reported in this study and classified as optimal (>32ng/mL), suboptimal (≤2ng/mL), insufficient (≤20ng/mL) and deficient (≤15ng/mL) levels. Serum 25-OHD levels less than optimal were reported in 58.5% of patients, and insufficient or deficient levels in 20.1%.

The association of vitamin D deficiency with risk factors is similar to that of the general population, when considering geographic areas with little exposure to sunlight at certain seasons of the year (winter and spring), dark skin, high BMI and lack of vitamin D supplementation, in addition to malabsorption of calcium and vitamin D due to intestinal lesion and chronic use of medications, especially corticosteroids. Pappa et al,³⁰ in 2006, analyzed the status of vitamin D in children with IBD, in a cross-sectional study with 130 patients, and the prevalence of deficiency (≤15ng/mL of 25-OHD) and severe deficiency (≤15ng/mL of 25-OHD) of vitamin D was present in 34.6% and 10.8%, respectively.

Pappa et al,²⁹ in 2011, observed lower concentrations of 25-OHD in young patients with active disease; in severe disease; in those not receiving vitamin D supplements; in patients with some nutritional impairment; in patients with newly diagnosed disease, and in those with more extensive disease.

Levin et al ³¹ analyzed serum 25-OHD levels in 78 children and classified them as: severe deficiency (<30nmol/L); moderate deficiency (<51nmol/L) and insufficiency (between 51 and 70 nmol/L), and found 57.5% of individuals with serum 25-OHD levels lower than the ideal, and 19.2% with moderate or severe deficiency. The authors concluded that newly diagnosed patients had higher mean serum levels of 25-OHD when compared to those with long-term disease, and that patients with deficiency had longer time of exposure to corticosteroids. Other nutritional analyses were performed in the selected studies.

Aurangzeb et al,²² in 2011, found mean lower levels of serum leptin in children with IBD when compared to controls, 2.4 and 5.2pg/mL, respectively. Heyman et al,³² in 2009, found that folate levels in pediatric patients with untreated IBD was higher than that obtained in healthy controls, although folic acid intake was higher in the controls. They also observed that anemia in patients with IBD does not depend on folate levels. Sylvester et al,³³ in 2009, found that lean mass and bone mineralization were significantly lower in patients with IBD, when compared to controls.

Nutritional assessment in pediatric patients with IBDs

Of the 12 selected studies, almost all patients had data on height, weight and BMI, expressed directly or as z scores. Aurangzeb et al ²² observed that the BMI z score and weight-for-age percentile in IBD patients were significantly lower than in controls (p<0.05 and p<0.01, respectively). Heyman et al ³² found that the mean BMI in patients with IBDs was lower than in controls, but the difference was not significant (18.7 and 20.1kg/m² respectively, p=0.189). Thayu et al ²⁸ reported that patients with CD had significantly lower height and z scores of BMI than the control children (p<0.001).

Pappa et al,^{29 , 30} in two studies (2006 and 2011), analyzed height, age and BMI (z scores) and observed that high BMI is a risk factor for low 25-OHD levels (negative association). Kugathasan et al ²⁵ followed the weight and height for two years and observed that BMI increased significantly during the period, reaching normal rates when compared to controls, but lean mass values remained lower than that of controls, suggesting that BMI alone is not sufficient for nutritional assessment in these patients, and the association with other methods is necessary. Kugathasan et al ²⁵ showed that children with normal BMI can have IBDs, especially URC.

Crohn's Disease X Ulcerative Rectocolitis in Pediatric Patients

When comparing types of IBDs, there is a greater prevalence of nutritional impairment in patients with CD when compared to those with URC. Pappa et al ³⁰ observed that patients with CD have significantly lower mean z score values ​​of weight, height, and BMI when compared to those with URC (p=0.001, p=0.002 and p=0.03), as well as albumin values (p=0.02), suggesting greater severity in CD.

When assessing excess weight and obesity in children and adolescents, it was observed that despite the tendency for increased risk of obesity and overweight in IBD, CD patients had lower values ​​when compared to those with URC. Long et al ²⁴ found that the prevalence of obesity or overweight was 20% in patients with CD versus 30% of those with URC. CD patients with excess weight had higher rates of complications, such as IBD-related surgeries. Patients with URC who use corticosteroids have a greater association with excess weight.

Kugathasan et al ²⁵ found a prevalence of excess weight or obesity of approximately 10% in CD, and 20% to 30% in URC. The authors also observed that the BMI value at diagnosis depends on the type of disease, with less excess weight and a higher rate of malnutrition in patients with CD. Lee et al,²⁶ when assessing the linear growth of children and adolescents with IBD, found that growth delay is significantly more prevalent in CD than in URC, with growth problems in 88% of patients with CD and only 12% in those with URC. Unlike the previous observations, some studies found a higher prevalence of growth deficit in patients with URC.

Pappa et al ²⁹ observed that the mean concentration of serum 25-OHD was 8.2% lower in patients with URC, when compared to those with CD, but without statistical significance (p=0.12). Levin et al ³¹ observed significantly lower mean levels of 25-OHD (p=0.02) in patients with URC, when compared to CD patients with serum levels of 54.4nmol/L and 73.1nmol/L. In the study by Heyman et al,³² the mean folate level was similar in patients with CD and URC.

Discussion

The assessment of the nutritional status of children and adolescents with IBDs is crucial in the clinical follow-up, to ensure normal growth and development, to define appropriate drug and nutritional therapy, and promote a better quality of life. Another aspect is the need to prevent prolonged corticosteroid therapy, due to the consequent growth impairment.^{34 , 35} It is essential to identify nutritional deficiencies that usually manifest as decreased weight for height and/or height for age, as well as specific nutritional deficiencies in children and adolescents with IBDs, and pubertal delay in adolescents.

Therefore, the nutritional assessment can guide the dietary therapy and adequate supplementation and provide an early correction of nutrient deficiencies, helping to reduce disease activity and minimize symptoms.^{36 , 37}

The studies included in this review demonstrate that children and adolescents with IBDs, especially those with CD, may have nutritional impairment due to several factors, such as reduced food intake, malabsorption, high intestinal losses, increased energy expenditure due to chronic inflammation and medications.^{38 , 39} These effects can lead to problems such as malnutrition, underweight, growth and developmental delay, delayed onset of pubertal characteristics, anemia, osteopenia and osteoporosis, micro and macronutrient deficiencies, in addition to significant psychological problems related to self-image and social interaction with peers, difficulties in the onset of sexual activity and depression.⁴⁰

Other studies have shown that there is greater nutritional impairment in CD patients when compared to those with URC, as a consequence of the greater severity and extent of the affected area in the digestive tract. CD usually affects the small intestine segments responsible for absorption, as well as frequently affecting the colon and other parts of the digestive tract.^{35 - 37} Not only the extent of the involvement, but also the severity, presentation, extraintestinal manifestations and comorbidities that may impair the nutritional status should be taken into account.^{34 , 41}

If not identified and treated, malnutrition in pediatric patients may result in severe health problems, worsening prognosis and consequent reduction in immune competence, increased infections, growth and development delay, social problems and higher rates of comorbidities. Stunted growth and pubertal delay are significantly important manifestations in pediatric patients and may be the first clinical findings of this condition, an aspect observed in several studies^{35 - 37} emphasizing the growth delay, which was reported in 18 to 22% of patients.

Several studies have shown high rates of growth retardation, often preceding the intestinal manifestations, ranging between 5% and 88%, with CD patients experimenting higher rates of nutritional impairment when compared to patients with URC. In association with growth retardation, impairment of pubertal development is observed in 20-30% of patients, mainly in those with CD^{38 , 41 , 42} of multifactorial etiology.^{35 , 36}

Other explanations for growth delay are associated with the use of medications, especially corticosteroids and hormonal disturbances caused by both the direct effects of the inflammatory processes and pubertal delay. Children with an early diagnosis of IBD in prepubertal or pubertal stages deserve special attention regarding linear growth.^{35 , 37 , 42}

Another aspect is the change in the overweight or obesity profile in the pediatric population with IBDs, with a tendency to the increase in the number of patients with overweight or obesity, ranging from 9-34%, depending on the disease subtype, with a higher prevalence in patients with URC. In a study carried out in the United States, high BMI was found in 20-30% of patients, with the highest values ​​in patients with ulcerative rectocolitis.⁴¹ This increase in rates of overweight and obesity in pediatric patients with IBDs may be explained, in part, by the epidemic of metabolic syndrome that occurs worldwide, due to changes in eating habits.

Studies have shown that deficiencies of minerals, trace elements and vitamins are common in patients with IBDs, with vitamin D deficiency being the most common, reaching 60% in some cases.⁴¹ These several deficiencies reflect chronic blood loss, chronic diarrhea or impairment of specific absorption sites, in addition to malabsorption due to the extent of inflammation, or surgical resections.³⁴ In some studies, the most common deficiency was that of vitamin D in patients with URC, when compared to those with CD, differing from publications in the literature that showed a higher prevalence in patients with CD.^{38 , 40}

Conclusions

A limited number of articles was found, and no studies on this subject have been carried out in South America. Nutritional alterations of multifactorial etiology can be found in inflammatory bowel diseases in children, especially growth and pubertal delay, underweight and vitamin deficiencies.

The reported nutritional impairments were more significant in patients with Crohn's disease, and overweight and obesity more common in ulcerative rectocolitis. A detailed nutritional assessment should be performed periodically in all children and adolescents with inflammatory bowel diseases, combined with different methods and multidisciplinary resources. More studies are needed in the pediatric age range with larger sample sizes.

References

• ¹
  Heyman MB, Kirschner BS, Gold BD, Ferry G, Baldassano R, Cohen SA et al. Children with early-onset inflammatory bowel disease (IBD): analysis of a pediatric IBD consortium registry. J Pediatr 2005;146:35-40.
• ²
  Salviano FN, Burgos MG, Santos EC. Perfil socioeconômico e nutricional de pacientes com doença inflamatória intestinal internados em um hospital universitário. Arq Gastroenterol 2007;2:99-106.
• ³
  Zhou N, Chen W, Chen S, Xu C, Li Y. Inflammatory bowel disease unclassified. J Zhejiang Univ Sci B 2011;12:280-6.
• ⁴
  Vagianos K, Bector S, McConnell J, Bernstein CN. Nutrition assessment of patients with inflammatory bowel disease. JPEN J Parenter Enteral Nutr 2007;31:311-9.
• ⁵
  Sandhu BK, Fell JM, Beattie RM, Mitton SG, Wilson DC, Jenkins H et al. Guidelines for the management of inflammatory bowel disease in children in the United Kingdom. J Pediatr Gastroenterol Nutr 2010;50 (Suppl 1):S1-13.
• ⁶
  Silverberg MS, Satsangi J, Ahmad T, Arnott I, Bernstein CN, Brant SR et al. Toward an integrated clinical , molecular and serological classification of inflammatory bowel disease. Can J Gastroenterol 2005;19 (Suppl A):5A-36.
• ⁷
  Satsangi J, Silverberg MS, Vermeire S, Colombel JF. The Montreal classification of inflammatory bowel disease: controversies, consensus, and implications. Gut 2006;55:749-53.
• ⁸
  Ausiello D, Goldman L. Cecil Medicina. 23th. Rio de Janeiro: Elsevier; 2010.
• ⁹
  Prince A, Whelan K, Moosa A, Lomer MC, Reidlinger DP. Nutritional problems in inflammatory bowel disease: the patient perspective. J Crohns Colitis 2011;5:443-50.
• ¹⁰
  Rodrigues SC, Passoni CM, Paganotto M. Aspects nutricionais in the Crohn illness. Cadernos da Escola de Saude 2008:1-8.
• ¹¹
  Gassull MA, Abad A, Cabré E, González-Huix F, Giné JJ, Dolz C. Enteral nutrition in inflammatory bowel disease. Gut 1986;27 (Suppl 1):76-80.
• ¹²
  Fisher RL. Wasting in chronic gastrointestinal diseases. J Nutr 1999;129:252-5.
• ¹³
  Nanau RM, Neuman MG. Nutritional and probiotic supplementation in colitis models. Dig Dis Sci 2012;57:2786-810.
• ¹⁴
  Camilleri M, Dubois D, Coulie B, Jones M, Kahrilas PJ, Rentz AM et al. Prevalence and socioeconomic impact of upper gastrointestinal disorders in the United States: results of the US upper gastrointestinal study. Clin Gastroenterol Hepatol 2005;3565:543-52.
• ¹⁵
  Cali AM, Caprio S. Obesity in children and adolescents. J Clin Endocrinol Metab 2008;93 (Suppl 1):S31-6.
• ¹⁶
  Sarni RO, Carvalho M de D, Monte CM, Albuquerque ZP, Souza FI. Anthropometric evaluation, risk factors for malnutrition, and nutritional therapy for children in teaching hospitals in Brazil. J Pediatr (Rio J) 2009;85:223-8.
• ¹⁷
  Burgos MG, Salviano FN, Belo GM, Bion FM. DII: o que há de novo em terapia nutricional?. Rev Bras Nutr Clin 2008;184-9.
• ¹⁸
  Silva ML, Dias MC, Vasconcelos MI, Sapucahy MV, Catalani LA, Miguel BZ et al. Sociedade Brasileira de Nutrição Parenteral e Enteral; Associação Brasileira de Nutrologia. Terapia nutricional na doença de Crohn. São Paulo: AMB/CFM; 2011.
• ¹⁹
  Campos FG, Waitzberg DL, Teixeira MG, Mucerino DR, Habr-Gama A, Kiss DR. Inflammatory bowel diseases: principles of nutritional therapy. Rev Hosp Clin Fac Med S Paulo 2002;57: 187-98.
• ²⁰
  Lopes A, Oliveira AF, Bleil RT. Apostila de avaliação nutricional I [cited 2014 Jan 01]. Available from:http://www.nutricaoemfoco.com.br/NetManager/documentos/apostila.av.nutricional.pdf
  » http://www.nutricaoemfoco.com.br/NetManager/documentos/apostila.av.nutricional.pdf
• ²¹
  Brasil - Ministério da Saúde. Secretaria de Atenção à Saúde - departamento de atenção básica. Incorporação da curvas de crescimento da Organização Mundial da Saúde de 2006 e 2007 no SISVAN. Brasília: SISVAN; 2007.
• ²²
  Aurangzeb B, Leach ST, Lemberg DA, Day AS. Assessment of nutritional status and serum leptin in children with inflammatory bowel disease. J Pediatr Gastroenterol Nutr 2011;52:536-41.
• ²³
  Wiskin AE, Wootton SA, Hunt TM, Cornelius VR, Afzal NA, Jackson AA et al. Body composition in childhood inflammatory bowel disease. Clin Nutr 2011;30:112-5.
• ²⁴
  Long MD, Crandall WV, Leibowitz IH, Duffy L, del Rosario F, Kim SC et al. Prevalence and epidemiology of overweight and obesity in children with inflammatory bowel disease. Inflamm Bowel Dis 2012;17:2162-8.
• ²⁵
  Kugathasan S, Nebel J, Skelton JA, Markowitz J, Keljo D, Rosh J et al. Body mass index in children with newly diagnosed inflammatory bowel disease: observations from two multicenter North American inception cohorts. J Pediatr 2007;151:523-7.
• ²⁶
  Lee JJ, Escher JC, Shuman MJ, Forbes PW, Delemarre LC, Harr BW et al. Final adult height of children with inflammatory bowel disease is predicted by parental height and patient minimum height Z-score. Inflamm Bowel Dis 2010;16: 1669-77.
• ²⁷
  Hood HC, Cohen LE, Lee JJ. Late adolescent linear growth pattern in pediatric-onset inflammatory bowel disease. J Pediatr Gastroenterol Nutr 2011;53:246-9.
• ²⁸
  Thayu M, Shults J, Burnham JM, Zemel BS, Baldassano RN, Leonard MB. Gender differences in body compositions deficits at diagnosis in children and adolescents with crohn's disease. Inflamm Bowel Dis 2009;13:1121-8.
• ²⁹
  Pappa HM, Langereis EJ, Grand RJ, Gordon CM. Prevalence and risk factors for hypovitaminosis D in young patients with inflammatory bowel disease: a retrospective study. J Pediatr Gastroenterol Nutr (New York) 2011;53:361-4.
• ³⁰
  Pappa HM, Gordon CM, Saslowsky TM, Zholudev A, Horr B, Shih M et al. Vitamin D status in children and young adults with inflammatory bowel disease. Pediatrics 2006;118:1950-61.
• ³¹
  Levin AD, Wadhera V, Leach ST, Woodhead HJ, Lemberg DA, Mendoza-Cruz AC et al. Vitamin D de?ciency in children with inflammatory bowel disease. Dig Dis Sci 2011;56:830-6.
• ³²
  Heyman MB, Garnett EA, Shaikh N, Huen K, Jose FA, Harmatz P et al. Folate concentrations in pediatric patients with newly diagnosed inflammatory bowel disease. Am J Clin Nutr 2009;545-50.
• ³³
  Sylvester FA, Leopold S, Lincoln M, Hyams JS, Griffiths AM, Lerer T. A two-year longitudinal study of persistent lean tissue de?cits in children with Crohn's disease. Clin Gastroenterol Hepatol (Philadelphia) 2009;7:452-5.
• ³⁴
  Alastair F, Emma G, Emma P. Nutrition in inflammatory bowel disease. JPEN J Parenter Enteral Nutr 2011;35:571-80.
• ³⁵
  Kappelman MD, Bousvaros A. Nutritional concerns in pediatric inflammatory bowel disease patients. Mol Nutr Food Res 2008; 52:867-74
• ³⁶
  Mallon DP, Suskind DL. Nutrition in pediatric inflammatory bowel disease. Nutr Clin Pract 2010;25:335-9.
• ³⁷
  Conklin LS, Oliva-Hemker M. Nutritional considerations in pediatric inflammatory bowel disease. Expert Rev Gastroenterol Hepatol 2010;4:305-17.
• ³⁸
  Gurram B, Joeckel R, Stephens M. Nutrition in pediatric inflammatory bowel disease. Nutr Clin Practice (Baltimore). 2010; 25:335-9.
• ³⁹
  Shamir R. Nutritional aspects in inflammatory bowel disease. J Pediatr Gastroenterol Nutr 2009;48 (Suppl 2):S86-8
• ⁴⁰
  Taminiau JA. Review article: the clinical importance of growth in children with inflammatory bowel disease: is it important to the gastroenterologist? Aliment Pharmacol Ther 2007;26 (Suppl 2):53-6.
• ⁴¹
  Gerasimidis K, McGrogan P, Edwards CA. The aetiology and impact of malnutrition in paediatric inflammatory bowel disease. J Hum Nutr Dietetics 2011;24:313-26.
• ⁴²
  Hartman C, Eliakim R, Shamir R. Nutritional status and nutritional therapy in inflammatory bowel diseases. World J Gastroenterol 2009;15:2570-8.

• ☆
  Study conducted at the Service of Pediatric Gastroenterology and Hepatology (Complexo HUPES-CPPHO) and Faculdade de Medicina da Bahia, Universidade Federal da Bahia, Salvador, BA, Brazil.

Publication Dates

• Publication in this collection
  Oct-Dec 2014

History

• Received
  19 Dec 2013
• Accepted
  07 Apr 2014